BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 22055020)

  • 21. Rapid flow cytometric test using eosin-5-maleimide for diagnosis of red blood cell membrane disorders.
    Tachavanich K; Tanphaichitr VS; Utto W; Viprakasit V
    Southeast Asian J Trop Med Public Health; 2009 May; 40(3):570-5. PubMed ID: 19842445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toward the harmonization of result presentation for the eosin-5'-maleimide binding test in the diagnosis of hereditary spherocytosis.
    Hunt L; Greenwood D; Heimpel H; Noel N; Whiteway A; King MJ
    Cytometry B Clin Cytom; 2015 Jan; 88(1):50-7. PubMed ID: 25227211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delay in the measurement of eosin-5′-maleimide (EMA) binding does not affect the test result for the diagnosis of hereditary spherocytosis.
    Ciepiela O; Kotuła I; Górska E; Stelmaszczyk-Emmel A; Popko K; Szmydki-Baran A; Adamowicz-Salach A; Demkow U
    Clin Chem Lab Med; 2013 Apr; 51(4):817-23. PubMed ID: 23023797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flow cytometry as a diagnostic tool for hereditary spherocytosis.
    Stoya G; Gruhn B; Vogelsang H; Baumann E; Linss W
    Acta Haematol; 2006; 116(3):186-91. PubMed ID: 17016037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Splenectomy in children with "mild" hereditary spherocytosis.
    Roy SM; Buchanan GR; Crary SE
    J Pediatr Hematol Oncol; 2013 Aug; 35(6):430-3. PubMed ID: 23823113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative evaluation of Eosin-5'-maleimide flow cytometry reveals a high diagnostic efficacy for hereditary spherocytosis.
    Joshi P; Aggarwal A; Jamwal M; Sachdeva MU; Bansal D; Malhotra P; Sharma P; Das R
    Int J Lab Hematol; 2016 Oct; 38(5):520-6. PubMed ID: 27339613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hereditary spherocytosis].
    Ideguchi H
    Nihon Rinsho; 1996 Sep; 54(9):2478-83. PubMed ID: 8890582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hereditary spherocytosis; new guidelines.
    Bolton-Maggs PH
    Arch Dis Child; 2004 Sep; 89(9):809-12. PubMed ID: 15321852
    [No Abstract]   [Full Text] [Related]  

  • 29. [Flow cytometric test using eosin-5'-maleimide (EMA) labelling of red blood for diagnosis of hereditary spherocytosis].
    Wang J; Zheng B; Zhao Y; Chen X; Liu Y; Bo L; Zheng Y; Zhang F; Ru K; Wang H
    Zhonghua Xue Ye Xue Za Zhi; 2015 Jul; 36(7):598-601. PubMed ID: 26304086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hereditary spherocytosis: clinical characteristics and treatment with splenectomy].
    Jonte F; Ramírez A; Medina J; García Gala J; Rosón C; Corte JR; Vargas M; Pérez Lozana L
    Sangre (Barc); 1995 Feb; 40(1):45-8. PubMed ID: 7716671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of splenectomy in hereditary spherocytosis by dual angle laser light cytometry.
    Ricard MP; Gilsanz F
    Clin Lab Haematol; 1996 Dec; 18(4):249-51. PubMed ID: 9054697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hereditary spherocytosis. Apropos of 4 cases].
    Muxi F; Cat JM; Manzano O; Genta M; Touya JJ; Rodriguez A; Lapido G; Giudice D; Ferreira WA; Rivero R; Chiessa de Krause D
    An Fac Med Univ Repub Montev Urug; 1966; 51(1):175-86. PubMed ID: 6015083
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluating eosin-5-maleimide binding as a diagnostic test for hereditary spherocytosis in newborn infants.
    Christensen RD; Agarwal AM; Nussenzveig RH; Heikal N; Liew MA; Yaish HM
    J Perinatol; 2015 May; 35(5):357-61. PubMed ID: 25357094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Exchange transfusion and splenectomy for hyperbilirubinemia caused by hereditary spherocytosis in the neonatal period].
    Reddemann H
    Z Kinderheilkd; 1967; 100(3):192-204. PubMed ID: 5595863
    [No Abstract]   [Full Text] [Related]  

  • 35. Genotype-phenotype correlation in children with hereditary spherocytosis.
    Tole S; Dhir P; Pugi J; Drury LJ; Butchart S; Fantauzzi M; Langer JC; Baker JM; Blanchette VS; Kirby-Allen M; Carcao MD
    Br J Haematol; 2020 Nov; 191(3):486-496. PubMed ID: 32436265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of cytochemical tests in gene analysis of hereditary spherocytosis: a case study of six patients with different disease subtypes.
    Shibuya A; Kawashima H; Tanaka M
    Hematology; 2021 Dec; 26(1):827-834. PubMed ID: 34672909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening and confirmation of hereditary spherocytosis in children using a CELL-DYN Sapphire haematology analyser.
    Rooney S; Hoffmann JJ; Cormack OM; McMahon C
    Int J Lab Hematol; 2015 Feb; 37(1):98-104. PubMed ID: 24739214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hereditary Spherocytosis in the Neonatal Period: A Case Report.
    Will A; Henderson CA; Jnah AJ; Newberry D
    Neonatal Netw; 2017 Sep; 36(5):280-288. PubMed ID: 28847351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinico-hematological profile of hereditary spherocytosis: experience from a tertiary care center in North India.
    Kar R; Rao S; Srinivas UM; Mishra P; Pati HP
    Hematology; 2009 Jun; 14(3):164-7. PubMed ID: 19490762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of asymptomatic gallstones in children with hereditary spherocytosis requiring splenectomy.
    Liu Y; Jin S; Li Y; Xu R; Pang W; Wang K; Wang Z; Chen Y
    J Pediatr Surg; 2023 Apr; 58(4):756-761. PubMed ID: 36588038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.